fbpx
  • Home
  • Study Details
By physician referral or invitation only

Using PSMA-PET/MRI for Unfavorable-Risk Prostate Cancer Patients Receiving Radiation

To determine the feasibility and toxicity of using prostate-specific membrane antigen-positron emission tomography (PSMA-PET) and multi-parametric magnetic resonance imagining (mpMRI) to guide target volumes for patients with unfavorable-risk prostate cancer receiving radiation.

Age & Gender

  • 18 years ~ 99 years
  • Male

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Panayiotis Mavroidis
Radiation Oncology - Chapel Hill

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Prostate)

IRB Number

19-0843

ClinicalTrials.gov

NCT04176497

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research